HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMUNEONCO-B

6.440

+0.0500.78%

Volume:1.04M

Turnover:6.68M

Market Cap:2.62B

PE:-7.16

High:6.520

Open:6.360

Low:6.270

Close:6.390

Loading ...

Overview Company News Filings

BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit

ImmuneOnco Biopharmaceuticals Shanghai Inc - Estimated That Loss on Disposal May Vary Between RMB0.7 Mln and RMB27.4 Mln

THOMSON REUTERS

ImmuneOnco Biopharmaceuticals Shanghai Inc - Disposal of Stake in Unit

THOMSON REUTERS

ImmuneOnco Biopharmaceuticals Doses 1st Patient in NMOSD Drug Trial

MT Newswires Live

ImmuneOnco Biopharmaceuticals Gets Phase 2 Trial Approval for Autoimmune Disease Drug

MT Newswires Live

BRIEF-Immuneonco Biopharmaceuticals Shanghai Gets Approval By NMPA For Phase II Clinical Trial Of IMM0306

ImmuneOnco Biopharmaceuticals Shanghai - Approval by Nmpa for Phase Ii Clinical Trial of Imm0306 for Treatment of Lupus Nephritis

THOMSON REUTERS

ImmuneOnco Biopharmaceuticals Raises HK$229.7 Million from Share Placement

MT Newswires Live

BUZZ-HK-listed ImmuneOnco Biopharma slumps on discounted share sale

ImmuneOnco Biopharmaceuticals Seeks HK$230 Million in Placement Deal; Shares Fall 6%

MT Newswires Live

BRIEF-Immuneonco Biopharmaceuticals Shanghai Announces Placing Of New H Shares

ImmuneOnco Biopharmaceuticals Shanghai Inc - to Place Total of 33.2 Mln New H Shares at Placing Price of HK$7.05 per Share

THOMSON REUTERS

ImmuneOnco Biopharmaceuticals Enrolls Patients in IMM0306 Clinical Trial

MT Newswires Live

Stock Track | ImmuneOnco Soars on Leukemia Drug's Phase 3 Trial Initiation

ImmuneOnco Biopharmaceuticals Doses First Patient in Phase 3 Leukemia Drug Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01541/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":6.44,"timestamp":1746778087029,"preClose":6.39,"halted":0,"volume":1040400,"delay":0,"floatShares":382000000,"shares":407000000,"eps":-0.8997257384310218,"marketStatus":"Market Closed","change":0.05,"latestTime":"05-09 16:08:07","open":6.36,"high":6.52,"low":6.27,"amount":6683087,"amplitude":0.039124,"askPrice":6.44,"askSize":11000,"bidPrice":6.38,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.8997257384310218,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":7,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":6.39,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.5488499683709158,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":382000000,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.899726,"volumeRatio":0.5488499683709158,"shares":407000000,"dividePrice":0,"high":6.52,"amplitude":0.039124,"preClose":6.39,"low":6.27,"week52Low":3.21,"pbRate":"3.59","psRate":"30.67","week52High":22,"institutionHeld":0,"latestPrice":6.44,"committee":-0.964286,"eps":-0.8997257384310218,"divideRate":0,"volume":1040400,"delay":0,"ttmEps":-0.8997257384310218,"open":6.36,"prevYearClose":5.16,"prevWeekClose":6.37,"prevMonthClose":6.25,"prevQuarterClose":5.84,"fiveDayClose":6.25,"twentyDayClose":4.91,"sixtyDayClose":5.45},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495352913","title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2495352913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495352913?lang=en_us&edition=fundamental","pubTime":"2024-12-30 23:24","pubTimestamp":1735572296,"startTime":"0","endTime":"0","summary":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Disposes Of Stake In UnitDec 30  - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:DISPOSAL OF STAKE IN UNITMAXIMUM AMOUNT OF PURCHASE PRICE FOR DISPOSAL RMB98.2 MILLIONESTIMATED THAT LOSS ON DISPOSAL MAY VARY BETWEEN RMB0.7 MILLION AND RMB27.4 MILLIONFurther company coverage: 1541.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2495459255","title":"ImmuneOnco Biopharmaceuticals Shanghai Inc - Estimated That Loss on Disposal May Vary Between RMB0.7 Mln and RMB27.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2495459255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495459255?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:12","pubTimestamp":1735560737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2495454594","title":"ImmuneOnco Biopharmaceuticals Shanghai Inc - Disposal of Stake in Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2495454594","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495454594?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:12","pubTimestamp":1735560737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS0AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2492953317","title":"ImmuneOnco Biopharmaceuticals Doses 1st Patient in NMOSD Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492953317","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492953317?lang=en_us&edition=fundamental","pubTime":"2024-12-17 19:48","pubTimestamp":1734436082,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals  dosed the first patient in a phase Ib clinical trial of IMM0306, a Tuesday bourse filing said.The drug is being tested for the treatment of neuromyelitis optica spectrum disorder  and no adverse events have been reported, according to the pharmaceutical firm.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488642779","title":"ImmuneOnco Biopharmaceuticals Gets Phase 2 Trial Approval for Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2488642779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488642779?lang=en_us&edition=fundamental","pubTime":"2024-12-02 15:19","pubTimestamp":1733123947,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved ImmuneOnco Biopharmaceuticals'  phase 2 trial for its IMM0306 drug for lupus nephritis, according to a Monday filing with the Hong Kong Exchange.Lupus nephritis is an autoimmune condition which lets the immune system attack its own organs.The drug binds the cluster of differentiation 47 to CD20, which helps eliminate malignant B cells that help tumor growth, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488616188","title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Gets Approval By NMPA For Phase II Clinical Trial Of IMM0306","url":"https://stock-news.laohu8.com/highlight/detail?id=2488616188","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488616188?lang=en_us&edition=fundamental","pubTime":"2024-12-02 09:19","pubTimestamp":1733102388,"startTime":"0","endTime":"0","summary":"Dec 2 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc   :   * APPROVAL BY NMPA FOR PHASE II CLINICAL TRIAL OF IMM0306 FOR TREATMENT OF LUPUS NEPHRITIS Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488692003","title":"ImmuneOnco Biopharmaceuticals Shanghai - Approval by Nmpa for Phase Ii Clinical Trial of Imm0306 for Treatment of Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488692003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488692003?lang=en_us&edition=fundamental","pubTime":"2024-12-02 06:41","pubTimestamp":1733092884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241201:nFWN3N00QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2487535199","title":"ImmuneOnco Biopharmaceuticals Raises HK$229.7 Million from Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2487535199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487535199?lang=en_us&edition=fundamental","pubTime":"2024-11-29 17:33","pubTimestamp":1732872833,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals   has completed the placement of 33,150,000 shares to at least six investors at HK$7.05 apiece to raise net proceeds of HK$229.7 million, a Thursday bourse filing said.The shares represent around 8.14% of the pharmaceutical company's enlarged issued share capital.The company will use proceeds from the placement to fund clinical studies of different drugs.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2485966435","title":"BUZZ-HK-listed ImmuneOnco Biopharma slumps on discounted share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2485966435","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485966435?lang=en_us&edition=fundamental","pubTime":"2024-11-21 13:53","pubTimestamp":1732168412,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed ImmuneOnco Biopharma slumps on discounted share sale ** Shares of ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK slump 11.2% to HK$7.48, on course for the biggest one-day pct decline since Oct. 14** Stock on track to snap two consecutive sessions of gain** The Chinese biotechnology group plans sale of 33.15 mln new shares, representing 8.14% of the enlarged share capital, to third party investors, raising HK$233.71 mln  to fund clinical studies for treatment of solid tumors in China** The new shares will be issued at HK$7.05 apiece, or 16.27% discount to Wednesday's close of HK$8.42 ** Hang Seng Commerce & Industry Index .HSNC slips 0.1%, while healthcare index .HSCIH and Hang Seng Index .HSI each eases 0.3%** Stock down 73.9% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL1N3MS05Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2485486749","title":"ImmuneOnco Biopharmaceuticals Seeks HK$230 Million in Placement Deal; Shares Fall 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485486749","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485486749?lang=en_us&edition=fundamental","pubTime":"2024-11-21 11:10","pubTimestamp":1732158651,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals   plans to sell 33,150,000 shares at HK$7.05 apiece to investors under a placement deal, according to a Thursday filing with the Hong Kong Exchange.The shares represent 8.14% of the pharmaceutical company's shareholding as enlarged by the placement.Net proceeds of HK$229.7 million, will be used to fund studies for its non-small cell lung cancer, triple-negative breast cancer, and tumor treatments, and for working capital.Shares slid 6% during Thursday's trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2485101081","title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Announces Placing Of New H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2485101081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485101081?lang=en_us&edition=fundamental","pubTime":"2024-11-21 09:13","pubTimestamp":1732151607,"startTime":"0","endTime":"0","summary":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Announces Placing Of New H SharesNov 21  - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:PLACING OF NEW H SHARESTO PLACE TOTAL OF 33.2 MILLION NEW H SHARES AT PLACING PRICE OF HK$7.05 PER SHAREFurther company coverage: 1541.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MR0OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2485085172","title":"ImmuneOnco Biopharmaceuticals Shanghai Inc - to Place Total of 33.2 Mln New H Shares at Placing Price of HK$7.05 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2485085172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485085172?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:45","pubTimestamp":1732142718,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR0OG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2484866005","title":"ImmuneOnco Biopharmaceuticals Enrolls Patients in IMM0306 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484866005","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484866005?lang=en_us&edition=fundamental","pubTime":"2024-11-18 10:57","pubTimestamp":1731898629,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals   said that 27 evaluable patients for the Phase Ib/IIa clinical trial of IMM0306 in combination with lenalidomide for indolent lymphoma were enrolled during October, according to a Monday filing with the Hong Kong bourse.The cancer drug is known to simultaneously bind CD47 and CD20 expressed on malignant B cells, leading to improved therapeutic outcomes, the filing noted.The company's shares were down over 2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1125715818","title":"Stock Track | ImmuneOnco Soars on Leukemia Drug's Phase 3 Trial Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=1125715818","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125715818?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:04","pubTimestamp":1731413063,"startTime":"0","endTime":"0","summary":"Shares of ImmuneOnco Biopharmaceuticals  Co. Ltd.  surged 18.66% on Monday after the company announced a major clinical milestone for its lead drug candidate IMM01.The Chinese biotech firm dosed the first patient in a Phase 3 clinical trial evaluating IMM01  in combination with azacitidine for the first-line treatment of chronic myelomonocytic leukemia , a type of rare blood cancer.Initiation of this late-stage study marks an important inflection point for IMM01's clinical development program. P","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01541"],"gpt_icon":0},{"id":"2482708959","title":"ImmuneOnco Biopharmaceuticals Doses First Patient in Phase 3 Leukemia Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482708959?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:58","pubTimestamp":1731412696,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals   dosed the first patient in a phase III clinical trial of IMM01  in combination with azacitidine for the first-line treatment of chronic myelomonocytic leukemia, a Tuesday bourse filing said.Shares of the pharma firm closed nearly 16% higher on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post Market","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-05-09","current":-7.730765,"percent":0.61165,"low":-30.003263,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"high":-2.993766,"avg":-13.662537,"sd":8.274079,"marketCap":2623061555},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555}],"updateTime":1746884354642}}}